Department of Drug Administration takes action against 17 pharmacies in one month

The Department of Drug Administration says it took action against 17 pharmacies in the period of one month from mid-October to mid-November 2021. The post Department of Drug Administration takes action against 17 pharmacies in one month appeared first on OnlineKhabar English News.

सम्बन्धित सामग्री

DDA warns against operating online pharmacies

KATHMANDU, MARCH 28: The Department of Drug Administration (DDA) has instructed not to operate online pharmacies. Director General of the Department, Narayan Prasad Dhakal, said that he ordered the disclosure of online pharmacies after the online pharmacies were found to sell medicines through false and misleading advertising. According to Dhakal, no pharmacies had obtained a […] The post DDA warns against operating online pharmacies appeared first on Aarthiknews:: A leading business & economic news portal from Nepal.

DDA warns against operating online pharmacy

The Department of Drug Administration (DDA) has instructed not to operate online pharmacies.

Madhesh capital’s illegal drug shops close as officials intensify monitoring

In Janakpurdham, the capital of Madhesh, illegal drug shop owners have closed their shops following increased monitoring by the Department of Drug Administration. The post Madhesh capital’s illegal drug shops close as officials intensify monitoring appeared first on OnlineKhabar English News.

DDA issues directive not to use 103 antibiotic drugs

KATHMANDU, Sep 18: The government has issued a directive to the consumers and stakeholders against using 103 types of antibiotics.  Director General of the Department of Drug Administration (DDA) Narayan Prasad Dhakal said the directive has been issued to minimize, prevent

DDA directs for putting red line on label of antibiotic medicines

The Department of Drug Administration (DDA) has directed for putting red line on the label of antibiotic medicines.

DDA directs for putting red line on label of antibiotic medicines

The Department of Drug Administration (DDA) has directed for putting red line on the label of antibiotic medicines.

DDA bans sale of Bio-D drops

The Department of Drug Administration (DDA) has banned sales of a drug named Bio-D drops administered to children citing its side effects

Remdesivir to be produced in Nepal

KATHMANDU, May 20: Remdesivir, the medicine used for treatment of COVID-19 infected people, is to be manufactured within country itself.  This medicine is to be produced in Nepal after the Department of Drug Administration gave permission for the same.  Department's information officer Santosh KC said the Birgunj-based National Health Care has been given permission for manufacturing the medicine. He added that the permission has been given after observeing all the infrastructures of the pharmaceutical company. Before this, Remdesivir was imported from India and Bangladesh. The medicine costs approximately Rs 5,000. Vice President of National Health Care, Ajaya Pandey, said they are preparing to bring raw materials for the medicine from China after getting the permission.  According to him, the raw materials would be brought within May 31. The medicine would be produced in 15 days from that date and supplied to the market.

DCSCP carries out monitoring in seven hospitals in Kathmandu valley

KATHMANDU, May 7: The Department of Commerce, Supplies and Consumer Protection (DCSCP) has carried out monitoring in hospitals in the Kathmandu Valley. The Department with the help of the Department of Drug Administration, the District Administration Office, Kathmandu and Nepal Police on Thursday monitored seven hospitals in the Valley to check whether treatment and other service fees are as fixed by the government, sad the Department’s spokesperson Shiva Raj Sedain.  The monitoring followed complaints registered against many hospitals in the Valley accusing them of charging patients high treatment fees during Covid-19 pandemic. The seven hospital monitored by the Department included Civil Hospital in Minbhawan, Om Hospital and Medicare in Chabahil, Kathmandu Medical College in Sinamangal, HAMS Hospital in Sukedhara, Grande International Hospital in Tokha and Metro Hospital.  During the monitoring, the hospitals are found to have lacked remdesivir and enough beds and not following the health protocols, said Sedain. Likewise, there is disparity in treatment and other service fees among the hospitals, he said.  Following the monitoring, the hospitals have been directed to submit required documents for investigations.